- Home
- NOG vs NKTR Comparison
NOG vs NKTR Comparison
Compare NOG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOG | NKTR |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NOG | NKTR |
|---|---|---|
| Price | $18.58 | $69.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $31.14 | ★ $146.67 |
| AVG Volume (30 Days) | ★ 4.0M | 1.2M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,475,723,000.00 | $307,711,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 11.23 | ★ 86.00 |
| 52 Week Low | $17.18 | $21.02 |
| 52 Week High | $31.17 | $109.00 |
Technical Indicators
Market Signals| Indicator | NOG | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 54.70 |
| Support Level | N/A | $64.30 |
| Resistance Level | $22.86 | $76.67 |
| Average True Range (ATR) | 0.74 | 4.38 |
| MACD | 0.19 | 1.21 |
| Stochastic Oscillator | 47.88 | 56.90 |
Price Performance
Historical ComparisonAbout NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.